SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
SOPHiA GENETICS SA (SOPH) Reports In-Line Q3 EPS
November 8, 2022 7:27 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.36), in-line with the analyst estimate of ($0.36). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $11.45 million.
2022 Outlook:
We are reaffirming our previously provided guidance of constant... More



